Moderna’s COVID-19 vaccine is 100% effective in children ages 12 to under 18, the company said Tuesday, in announcing results of their latest clinical trials.
In addition to its efficacy, the vaccine showed “no significant safety concerns” in the trial of more than 3,700 adolescent participants, according to Moderna, which said it plans to submit results of the trial to U.S. regulators and request authorization in early June.
Continue reading here.
